Literature DB >> 8557169

Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases.

Y Rouillé1, S J Duguay, K Lund, M Furuta, Q Gong, G Lipkind, A A Oliva, S J Chan, D F Steiner.   

Abstract

The recent discovery of a novel family of precursor processing endoproteases has greatly accelerated progress in understanding the complex mechanisms underlying the maturation of prohormones, neuropeptides, and many other precursor-derived proteins. At least six members of this family have been found thus far in mammalian species, several having alternatively spliced isoforms, and related enzymes have been identified in many invertebrates, including molluscs, insects, nematodes, and coelenterates. The proprotein convertases are all dependent on calcium for activity and all possess highly conserved subtilisin-like domains with the characteristic catalytic triad of this serine protease (ordered Asp, His, and Ser along the polypeptide chain). Two members of this family, PC2 (SPC2) and PC1/PC3 (SPC3), appear to play a preeminent role in neuroendocrine precursor processing. Both convertases are expressed only in the brain and in the extended neuroendocrine system, while another important family member--furin/PACE (SPC1)--is expressed more ubiquitously, in almost all tissues, and at high levels in liver. SPC2 and SPC3 exhibit acidic pH optima and other properties which enhance their activity in the acidic, calcium-enriched environment of the dense-core secretory granules of the regulated pathway in neuroendocrine cells, while furin has a neutral pH optimum and is localized predominantly to the trans Golgi network where it is retained by a C-terminal transmembrane domain. Furin processes a wide variety of precursors in the constitutive pathway, such as those of growth factors, receptors, coagulation factors, and viral glycoproteins. Recent findings on the processing of proopiomelanocortin, proinsulin, proglucagon, and several other neuroendocrine precursors by SPC2 and SPC3 are discussed, along with information on the structure, properties, evolution, developmental expression, and regulation of the convertases. An inherited defect in the fat/fat mouse which affects the processing of proinsulin, and probably also many other prohormones, due to a point mutation in carboxypeptidase E has recently been identified and has begun to provide new insights into the functional integration of the individual processing steps.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557169     DOI: 10.1006/frne.1995.1012

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  82 in total

1.  The Kex2p proregion is essential for the biosynthesis of an active enzyme and requires a C-terminal basic residue for its function.

Authors:  G Lesage; A Prat; J Lacombe; D Y Thomas; N G Seidah; G Boileau
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

2.  Deconstructing honeybee vitellogenin: novel 40 kDa fragment assigned to its N terminus.

Authors:  Heli Havukainen; Øyvind Halskau; Lars Skjaerven; Bente Smedal; Gro V Amdam
Journal:  J Exp Biol       Date:  2011-02-15       Impact factor: 3.312

3.  Human and rat testis express two mRNA species encoding variants of NRD convertase, a metalloendopeptidase of the insulinase family.

Authors:  V Hospital; A Prat; C Joulie; D Chérif; R Day; P Cohen
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  7B2 prevents unfolding and aggregation of prohormone convertase 2.

Authors:  Sang-Nam Lee; Iris Lindberg
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

5.  Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis.

Authors:  Xin Zhang; Hui Pan; Bonnie Peng; Donald F Steiner; John E Pintar; Lloyd D Fricker
Journal:  J Neurochem       Date:  2009-12-07       Impact factor: 5.372

6.  Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

Authors:  Y Coulouarn; I Lihrmann; S Jegou; Y Anouar; H Tostivint; J C Beauvillain; J M Conlon; H A Bern; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

7.  A model for the structure of the P domains in the subtilisin-like prohormone convertases.

Authors:  G M Lipkind; A Zhou; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 8.  Prohormone and proneuropeptide processing. Recent progress and future challenges.

Authors:  M C Beinfeld
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

9.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

10.  Carboxypeptidase E in rat antropyloric mucosa: distribution in progenitor and mature endocrine cell types.

Authors:  David M Hougaard; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2003-12-06       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.